Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-10 |
CI |
denotes |
Adalimumab |
T2 |
137-147 |
CI |
denotes |
adalimumab |
T3 |
366-376 |
CI |
denotes |
adalimumab |
T4 |
650-660 |
CI |
denotes |
adalimumab |
T5 |
1508-1518 |
CI |
denotes |
adalimumab |
T6 |
1789-1799 |
CI |
denotes |
adalimumab |
T7 |
38-47 |
DP |
denotes |
psoriasis |
T8 |
196-205 |
DP |
denotes |
psoriasis |
T9 |
468-477 |
DP |
denotes |
psoriasis |
T10 |
702-711 |
DP |
denotes |
Psoriasis |
Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
38-47 |
DP |
denotes |
psoriasis |
T2 |
196-205 |
DP |
denotes |
psoriasis |
T3 |
468-477 |
DP |
denotes |
psoriasis |
T4 |
702-711 |
DP |
denotes |
Psoriasis |
T5 |
0-10 |
CI |
denotes |
Adalimumab |
T6 |
137-147 |
CI |
denotes |
adalimumab |
T7 |
366-376 |
CI |
denotes |
adalimumab |
T8 |
650-660 |
CI |
denotes |
adalimumab |
T9 |
1508-1518 |
CI |
denotes |
adalimumab |
T10 |
1789-1799 |
CI |
denotes |
adalimumab |